You wear more health tech than ever — a watch, a ring, a CGM, a stack of lab PDFs. And they disagree. They live in separate apps that don't talk to each other. Sage + Stone reconciles every signal into one honest read you actually own.
The more you measure, the more contradictory the numbers get. Sage + Stone exists to end that.
Your watch logs one number for sleep; your ring logs another. Your CGM lives in its own app, your labs in a portal you forgot the password to. None of them agree, and none of them talk.
Sage + Stone pulls your wearables, CGM and labs into a single timeline, then reconciles the conflicts into one trustworthy read — instead of leaving you with five apps that argue.
A daily AI coach reads across every signal so you start each morning with one clear picture, not a spreadsheet of disagreements.
I'm [Your Name], the founder. I built Sage + Stone after [your personal frustration — e.g. spending a year wearing a watch, a ring and a CGM, and still not being able to answer a simple question about my own health because every app told me something different].
I'm [a sentence of honest background — what you do, what got you into health data, why this problem is personal to you. Keep it real; don't claim a degree, employer, or credential you don't have]. I'm not a doctor and Sage + Stone isn't a clinic — it's the layer I wished existed: one place that takes everything you already measure and turns it into a single honest read you own.
We're early — pre-launch, building in the open. If that mission resonates, I'd genuinely love for you to join the waitlist and help shape what we build. [Optional: add a line on how people can reach you, e.g. "Email me anything at founder@sageplusstone.com."]
about.html and find this section:
[Your Name] with your name (name heading, bio, and signature)..monogram initials (YN) — or swap the whole block for <img src="/img/founder.jpg"> per the <!-- TODO --> comment.There's a single thread running through everything we do — and it starts with reconciling your devices.
The Sage + Stone app and AI coach pull your wearables, CGM and labs into one consented timeline — and resolve the conflicts into a single honest read of you.
That reconciliation produces something rare: structured, multi-device health data you've explicitly consented to share — accurate enough to be useful, owned entirely by you.
Clinical trials have strict eligibility — age, biomarkers, conditions, device-tracked baselines. Most people never hear about the studies they'd qualify for, and recruitment is pharma's #1 bottleneck: a majority of trials run behind schedule because they can't find the right participants in time. The same consented, multi-device profile that gives you one honest read is exactly what lets us check your fit against live listings and surface trials you'd otherwise never see — on your terms, opt-in per share.
That's the whole flywheel: reconcile your devices → you own one honest read → that consented data powers fair trial matching. One serves the other.
We're early & pre-launch — this is the plan we're building toward, honestly stated
The flywheel only works if you trust us with the read. So the rules are simple, and they favor you.
Your health data is yours, full stop. Sage + Stone is the layer that organizes it — not the owner of it. You can export or delete it whenever you want.
Nothing is shared by default. Every share — including matching you to a trial — is opt-in, granular, and revocable. You approve each one, and you can take it back.
We do not sell your raw health data. The business model is the product and consented matching you opt into — not quietly auctioning your biology to data brokers.
We're building toward SOC 2 and hold ourselves to it as we grow. To be honest: we are not yet certified. We'll say so plainly here the day that changes.
Honest status: not yet certifiedThe full detail lives in our Privacy Policy.
Join the waitlist to shape Sage + Stone — or, if you run trials, see how consented matching can fill your studies faster.
Private by design · You own your data · Opt-in per share